Market revenue in 2023 | USD 11.2 million |
Market revenue in 2030 | USD 23.7 million |
Growth rate | 11.3% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 58.04% in 2023. Horizon Databook has segmented the South Korea deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is expected to grow at a considerably faster rate in the coming years owing to rising prevalence of neurological disorders such as PD, epilepsy, and brain tumors. PD, epilepsy, and other neurological disorders are age related, thus rise in geriatric population would lead to increase in the incidence of such conditions, thereby creating more opportunities in deep brain stimulation devices market.
Furthermore, Korea-US Free Trade Agreement (KORUS FTA) was implemented on March 15, 2012, thus, most of the medical devices in Korea received duty-free treatment. Moreover, mental health awareness programs are being conducted by many nonprofit organizations and institutions such as Department of Neurology (Y.S.K.), among others.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account